CoChat

Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study

Open access
Allemani, Claudia, Rachet, Bernard, Weir, Hannah K, Richardson, Lisa C, Lepage, Côme, Faivre, Jean, Gatta, Gemma, Capocaccia, Riccardo, Sant, Milena, Baili, Paolo, Lombardo, Claudio, Aareleid, Tiiu, Ardanaz, Eva, Bielska-Lasota, Magdalena, Bolick, Susan, Cress, Rosemary, Elferink, Marloes, Fulton, John P, Galceran, Jaume, Góźdź, Stanisław, Hakulinen, Timo, Primic-Žakelj, Maja, Rachtan, Jadwiga, Diba, Chakameh Safaei, Sánchez, Maria-José, Schymura, Maria J, Shen, Tiefu, Tagliabue, Giovanna, Tumino, Rosario, Vercelli, Marina, Wolf, Holly J, Wu, Xiao-Cheng, Coleman, Michel P · 2013 · BMJ Open
Cited by 92

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Objectives: To assess the extent to which stage at diagnosis and adherence to treatment guidelines may explain the persistent differences in colorectal cancer survival between the USA and Europe. Design: A high-resolution study using detailed clinical data on Dukes’ stage, diagnostic procedures, treatment and follow-up, collected directly from medical records by trained abstractors under a single protocol, with standardised quality control and central statistical analysis. Setting and participants: 21 population-based registries in seven US states and nine European countries provided data for random samples comprising 12 523 adults (15–99 years) diagnosed with colorectal cancer during 1996–1998. Outcome measures: Logistic regression models were used to compare adherence to ‘standard care’ in the USA and Europe. Net survival and excess risk of death were estimated with flexible parametric models. Results: The proportion of Dukes’ A and B tumours was similar in the USA and Europe, while that of Dukes’ C was more frequent in the USA (38% vs 21%) and of Dukes’ D more frequent in Europe (22% vs 10%). Resection with curative intent was more frequent in the USA (85% vs 75%). Elderly patients (75–99 years) were 70–90% less likely to receive radiotherapy and chemotherapy. Age-standardised 5-year net survival was similar in the USA (58%) and Northern and Western Europe (54–56%) and lowest in Eastern Europe (42%). The mean excess hazard up to 5 years after diagnosis was highest in Eastern Europe, especially among elderly patients and those with Dukes’ D tumours. Conclusions: The wide differences in colorectal cancer survival between Europe and the USA in the late 1990s are probably attributable to earlier stage and more extensive use of surgery and adjuvant treatment in the USA. Elderly patients with colorectal cancer received surgery, chemotherapy or radiotherapy less often than younger patients, despite evidence that they could also have benefited.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2013-003055

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 92

Metadata

Authors
Allemani, C., Rachet, B., Weir, H. K., Richardson, L. C., Lepage, C., Faivre, J., Gatta, G., Capocaccia, R., Sant, M., Baili, P., Lombardo, C., Aareleid, T., Ardanaz, E., Bielska-Lasota, M., Bolick, S., Cress, R., Elferink, M., Fulton, J. P., Galceran, J., Góźdź, S., Hakulinen, T., Primic-Žakelj, M., Rachtan, J., Diba, C. S., Sánchez, M.-J., Schymura, M. J., Shen, T., Tagliabue, G., Tumino, R., Vercelli, M., Wolf, H. J., Wu, X.-C., & Coleman, M. P.
Venue
BMJ Open
Publisher
BMJ
Published
2013-09-10
Volume
3
Issue
9
Pages
e003055
ISSN
2044-6055 (ISSN-L)
OpenAlex
W2114483695
Cited by
92
References
6
FWCI
4.43
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study. https://app.cochat.ai/papers/10.1136/bmjopen-2013-003055
The paper
Allemani, C., Rachet, B., Weir, H. K., Richardson, L. C., Lepage, C., Faivre, J., Gatta, G., Capocaccia, R., Sant, M., Baili, P., Lombardo, C., Aareleid, T., Ardanaz, E., Bielska-Lasota, M., Bolick, S., Cress, R., Elferink, M., Fulton, J. P., Galceran, J., . . . Coleman, M. P. (2013). Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study. BMJ Open. https://doi.org/10.1136/bmjopen-2013-003055

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.